Literature DB >> 12416994

Ellman's-reagent-mediated regeneration of trypanothione in situ: substrate-economical microplate and time-dependent inhibition assays for trypanothione reductase.

Chris J Hamilton1, Ahilan Saravanamuthu, Ian M Eggleston, Alan H Fairlamb.   

Abstract

Trypanothione reductase (TryR) is a key enzyme involved in the oxidative stress management of the Trypanosoma and Leishmania parasites, which helps to maintain an intracellular reducing environment by reduction of the small-molecular-mass disulphide trypanothione (T[S](2)) to its di-thiol derivative dihydrotrypanothione (T[SH](2)). TryR inhibition studies are currently impaired by the prohibitive costs of the native enzyme substrate T[S](2). Such costs are particularly notable in time-dependent and high-throughput inhibition assays. In the present study we report a protocol that greatly decreases the substrate quantities needed for such assays. This is achieved by coupling the assay with the chemical oxidant 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB), which can rapidly re-oxidize the T[SH](2) product back into the disulphide substrate T[S](2), thereby maintaining constant substrate concentrations and avoiding deviations from rate linearity due to substrate depletion. This has enabled the development of a continuous microplate assay for both classical and time-dependent TryR inhibition in which linear reaction rates can be maintained for 60 min or more using minimal substrate concentrations (<1 microM, compared with a substrate K (m) value of 30 microM) that would normally be completely consumed within seconds. In this manner, substrate requirements are decreased by orders of magnitude. The characterization of a novel time-dependent inhibitor, cis -3-oxo-8,9b-bis-(N(1)-acrylamidospermidyl)-1,2,3,4,4a,9b-hexahydrobenzofuran (PK43), is also described using these procedures.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12416994      PMCID: PMC1223126          DOI: 10.1042/BJ20021298

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress.

Authors:  S Krieger; W Schwarz; M R Ariyanayagam; A H Fairlamb; R L Krauth-Siegel; C Clayton
Journal:  Mol Microbiol       Date:  2000-02       Impact factor: 3.501

2.  Ellman's reagent: 5,5'-dithiobis(2-nitrobenzoic acid)--a reexamination.

Authors:  P W Riddles; R L Blakeley; B Zerner
Journal:  Anal Biochem       Date:  1979-04-01       Impact factor: 3.365

Review 3.  The behavior and significance of slow-binding enzyme inhibitors.

Authors:  J F Morrison; C T Walsh
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1988

4.  Expression, purification, and characterization of Mycobacterium tuberculosis mycothione reductase.

Authors:  M P Patel; J S Blanchard
Journal:  Biochemistry       Date:  1999-09-07       Impact factor: 3.162

5.  Synthesis of N-benzyloxycarbonyl-L-cysteinylglycine 3-dimethylaminopropylamide disulfide: a cheap and convenient new assay for trypanothione reductase.

Authors:  A el-Waer; K T Douglas; K Smith; A H Fairlamb
Journal:  Anal Biochem       Date:  1991-10       Impact factor: 3.365

6.  Synthesis of substrate analogues for trypanothione reductase.

Authors:  A F el-Waer; T Benson; K T Douglas
Journal:  Int J Pept Protein Res       Date:  1993-02

7.  Substrate interactions between trypanothione reductase and N1-glutathionylspermidine disulphide at 0.28-nm resolution.

Authors:  S Bailey; K Smith; A H Fairlamb; W N Hunter
Journal:  Eur J Biochem       Date:  1993-04-01

8.  2,4-Dihydroxybenzylamine: a specific inhibitor of glutathione reductase.

Authors:  G B FitzGerald; C Bauman; M S Hussoin; M M Wick
Journal:  Biochem Pharmacol       Date:  1991-01-15       Impact factor: 5.858

9.  Substrate specificity of the flavoprotein trypanothione disulfide reductase from Crithidia fasciculata.

Authors:  G B Henderson; A H Fairlamb; P Ulrich; A Cerami
Journal:  Biochemistry       Date:  1987-06-02       Impact factor: 3.162

10.  Purification and characterization of trypanothione reductase from Crithidia fasciculata, a newly discovered member of the family of disulfide-containing flavoprotein reductases.

Authors:  S L Shames; A H Fairlamb; A Cerami; C T Walsh
Journal:  Biochemistry       Date:  1986-06-17       Impact factor: 3.162

View more
  27 in total

1.  Trypanothione reductase high-throughput screening campaign identifies novel classes of inhibitors with antiparasitic activity.

Authors:  Georgina A Holloway; William N Charman; Alan H Fairlamb; Reto Brun; Marcel Kaiser; Edmund Kostewicz; Patrizia M Novello; John P Parisot; John Richardson; Ian P Street; Keith G Watson; Jonathan B Baell
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

2.  Phenotypic analysis of trypanothione synthetase knockdown in the African trypanosome.

Authors:  Mark R Ariyanayagam; Sandra L Oza; Maria Lucia S Guther; Alan H Fairlamb
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

3.  High-throughput screening affords novel and selective trypanothione reductase inhibitors with anti-trypanosomal activity.

Authors:  Derek C Martyn; Deuan C Jones; Alan H Fairlamb; Jon Clardy
Journal:  Bioorg Med Chem Lett       Date:  2006-12-09       Impact factor: 2.823

4.  Discovery of 2-iminobenzimidazoles as a new class of trypanothione reductase inhibitor by high-throughput screening.

Authors:  Georgina A Holloway; Jonathan B Baell; Alan H Fairlamb; Patrizia M Novello; John P Parisot; John Richardson; Keith G Watson; Ian P Street
Journal:  Bioorg Med Chem Lett       Date:  2006-12-03       Impact factor: 2.823

5.  Pseudoirreversible slow-binding inhibition of trypanothione reductase by a protein-protein interaction disruptor.

Authors:  Héctor de Lucio; Miguel A Toro; María-José Camarasa; Sonsoles Velázquez; Federico Gago; Antonio Jiménez-Ruiz
Journal:  Br J Pharmacol       Date:  2020-10-02       Impact factor: 8.739

6.  Increasing the activity of copper(II) complexes against Leishmania through lipophilicity and pro-oxidant ability.

Authors:  Andressa dos Santos Portas; Danilo Ciccone Miguel; Jenicer K U Yokoyama-Yasunaka; Silvia Reni Bortolin Uliana; Breno Pannia Espósito
Journal:  J Biol Inorg Chem       Date:  2011-08-25       Impact factor: 3.358

7.  Comparative structural, kinetic and inhibitor studies of Trypanosoma brucei trypanothione reductase with T. cruzi.

Authors:  Deuan C Jones; Antonio Ariza; Wing-Huen A Chow; Sandra L Oza; Alan H Fairlamb
Journal:  Mol Biochem Parasitol       Date:  2009-09-10       Impact factor: 1.759

8.  Investigation of trypanothione reductase as a drug target in Trypanosoma brucei.

Authors:  Daniel Spinks; Emma J Shanks; Laura A T Cleghorn; Stuart McElroy; Deuan Jones; Daniel James; Alan H Fairlamb; Julie A Frearson; Paul G Wyatt; Ian H Gilbert
Journal:  ChemMedChem       Date:  2009-12       Impact factor: 3.466

9.  Synthesis and evaluation of 1-(1-(Benzo[b]thiophen-2-yl)cyclohexyl)piperidine (BTCP) analogues as inhibitors of trypanothione reductase.

Authors:  Stephen Patterson; Deuan C Jones; Emma J Shanks; Julie A Frearson; Ian H Gilbert; Paul G Wyatt; Alan H Fairlamb
Journal:  ChemMedChem       Date:  2009-08       Impact factor: 3.466

10.  Improved tricyclic inhibitors of trypanothione reductase by screening and chemical synthesis.

Authors:  John L Richardson; Isabelle R E Nett; Deuan C Jones; Mohamed H Abdille; Ian H Gilbert; Alan H Fairlamb
Journal:  ChemMedChem       Date:  2009-08       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.